首页--医药、卫生论文--中国医学论文--中药学论文--中药化学论文

纳米脂质及其作为新型龙血竭的载体,和它的辐射防护生物学效应研究

Abstract第7-8页
摘要第9-11页
List of Symbols and Abbreviations第11-14页
Contents第14-19页
LIST OF FIGURES第19-21页
LST OF TABLES第21-22页
1. GENERAL INTRODUCTION第22-49页
    1.1. REVIEW OF LITERATURE第23-33页
        1.1.2. Recent Research on Radiation第23-25页
        1.1.3. Biomedical Effcts of Radiation第25-29页
        1.1.4. Occupational Radiation Exposure第29-30页
        1.1.5. Radiation Threats in Space第30-33页
    1.2. Anti-radiation Drugs Reaction & its Defense Mechanism第33-34页
    1.3. Promising Anti- Radiation Drugs第34-35页
    1.4. Screening of Antiradiation Drug from Natural Resources第35-36页
    1.5. History of Dragons Blood Resin第36-37页
    1.6. Biomedical Characterization of Dragons Blood Resin第37-42页
        1.6.1. Anti-thrombin activity第37-38页
        1.6.2. Anti-microbial and Anti-viral activity第38页
        1.6.3. Anti-tumor and cytotoxic activity第38-39页
        1.6.4. Anti-hemorrhagic activity第39页
        1.6.5. Immunomodulatory activity第39-40页
        1.6.6. Antiulcer and antidiarrhoeal activity第40-41页
        1.6.7. Analgesic activity第41页
        1.6.8. Antioxidative activity第41页
        1.6.9. Anti-inflammatory activity第41-42页
        1.6.10. Mutagenic and antimutagenic activity第42页
    1.7. Use of Nanoscience and Nanotechnology第42-47页
        1.7.1. Nanoliposomes第43-46页
            1.7.1.1. Sonication第44-45页
            1.7.1.2. Solvent injection第45-46页
        1.7.2. Nanoliposomes in drug delivery第46-47页
    1.8. Motivation of Purpose Study第47-49页
2. MATERIALS AND METHODS第49-61页
    2.1 Appratus and Reagents第49-50页
    2.2 Screening and determine the effective parts第50-53页
        2.2.1 Selection of method and preparing anti-radiation effective parts第50-51页
        2.2.2 Investigation of Ethanol Concentration after Dilution第51页
        2.2.3 Preparation of Effective Parts第51页
        2.2.4 Analysis of Effective Ingadient第51-52页
        2.2.5 HPLC-DAD-MS Method combines literature第52-53页
    2.3 Preparation of macroporous resin method第53-54页
        2.3.1 Static Adsorption & Desorption Ratio第53页
        2.3.2 Adsorption Rate第53页
        2.3.3 Desorption Rate第53-54页
    2.4 Macroporous Resin Models of Dynamic Filtering第54-56页
        2.4.1 Macroporous Resin Separation Effect第54页
        2.4.2 Examine the proportion of sample / resin第54页
        2.4.3 Preparation of Macroporous Resin in Enlarge Column第54-56页
    2.5 Biological Activity of Dragons Blood resin Fraction第56-58页
        2.5.1 Preparation of LX Fraction第56页
        2.5.2 Bioreducing Activity of LX第56页
        2.5.3 Stabilizing the AgNO_3Nanoparticles by Dragons Blood resin第56页
        2.5.4 Thin Film Evaporation Method for Synthesis of LX Loaded Nanoliposomes第56-57页
        2.5.6. Morphology of synthesisized Nanomaterials第57页
        2.5.7 FTIR第57页
        2.5.8 Encapsulation Efficiency第57-58页
    2.6. Cell Model Experiment第58-60页
        2.6.1 Cellular uptake of LX loaded nanoliposomes第59页
        2.6.2 Cell Cycle Assay via Annexin V第59页
        2.6.3 Quantification of Apoptosis by TUNEL assay第59-60页
        2.6.4 Western blot analysis第60页
    2.7 Statistics analysis第60-61页
3. RESULTS AND DISCUSSION第61-115页
    3.1 Dragons Blood resin extract第61-75页
        3.1.1 Screeing of Anti-Radiation Effective Parts.第61-64页
        3.1.2 HPLC-DAD-MS method combines literature Exploration effective component parts第64-67页
        3.1.3 Spectral analysis of Antiradiation Effective part from Dragons Blood第67-69页
        3.1.4 Enrichment and purification of bioactive compounds from Dragons Blood Resin Extract第69-71页
        3.1.5 Macroporous Resin Models of Dynamic Filtering第71-75页
    3.2 Bioreducing and Stabilizing Potential of Dragon‘s Blood第75-80页
        3.2.1 Biological Synthesis of Silver Nanoparticles第75-76页
        3.2.2 Effect of Temperature on synthesis of nanoparticles第76-77页
        3.2.3. Effect of Solevnt & Dragons Blood content on synthesis of nanoparticles第77-80页
        3.2.4. Identification of Bioreducing agent in Dragons Blood第80页
    3.3. Dual role of Dragon‘s Blood Resin第80-89页
        3.3.1 Stability of Silver Nanoparticle & Antiradiation activity第81-82页
        3.3.2 Characterization of nanoparticles第82-87页
        3.3.4 Ecofriendly Synthesis of nanoparticles第87-89页
    3.4 LX loaded Nanoliposomes synthesis, characterization第89-96页
        3.4.1 Cellular Uptake studies第89-90页
        3.4.2 Composition of Nanoliposomes第90-96页
        3.4.3 Summary第96页
    3.5 Downregulation of Tumour Inducing C-Fos C-Jun Expression第96-115页
        3.5.1 A Unique Antiradiation Defense Strategy第97-98页
        3.5.2 Preparation and characterization of LX loaded Nano-Liposomes第98-100页
        3.5.3 Drug Release Behaviour第100-101页
        3.5.4 Cytotoxicity of Nano liposomes第101-102页
        3.5.5 Cellular uptake of LX loaded Nanoliposomes第102-103页
        3.5.6 Apoptosis by Anexin第103-105页
        3.5.7 Cell cycle Cell Cycle studies第105-106页
        3.5.8 Western Blotting第106-107页
        3.5.9 Discussion第107-115页
CONCLUSION AND FUTURE WORK第115-118页
References第118-138页
ACKNOWLEDGEMENT第138-140页
PUBLICATIONS LIST第140-143页
附录第143-145页

论文共145页,点击 下载论文
上一篇:骨关节炎关节软骨祖细胞功能活性及miRNA表达谱的改变
下一篇:基于Hausdorff距离的参数估计收敛性分析